Cannabigerol, or CBG, is one such compound that is gaining much popularity and interest in the field of medicine. It has long been relegated to the background while THC (tetrahydrocannabinol) and CBD (cannabidiol) took center stage, also known as its mother cannabinoid. Now, there is an increasing interest in CBG, although still not as high as CBD or THC. As the field of cannabinoid research is rapidly growing and more CBG studies are revealing its medicinal power, it seems to hold much promise for the medicine of tomorrow.
What is CBG?
Cannabis contains a variety of phytocannabinoids, one of which is CBG, or cannabigerol, often called the ‘stem cell’ or ‘mother cannabinoid’ because it is converted into THC, CBD, and the remaining cannabinoids and terpenes during its biosynthetic process. As the plant matures, most of the CBG found in cannabis gets transformed into other cannabinoids, and mature cannabis plant strains are left with only CBG traces. Its study has been inhibited until now because it is rare, but the development of cannabis cultivation technology, as well as selective breeding and genetic engineering, makes it available to extract for scientific purposes.
CBG, in contrast to THC, is not psychoactive. Even though it does not produce the usual sensations of euphoria that are commonly seen with the usage of cannabis, CBG has the potential to act on the endocannabinoid system (ECS) CB1 and CB2 receptors in the human body. CBG does not have the intoxicating qualities of THC, so it has the potential to be used for therapeutic purposes in a large number of diseases.
What Makes CBG Terpenes Special in the World of Cannabis?
CBG terpenes are particular aromatic compounds that are present in cannabis particularly rich in CBG. In contrast to other cannabis terpenes which may include limonene, linalool, myrcene and caryophyllene, CBG terpenes might be functioning differently, possibly improving the overall impact of CBG.
These terpenes are essential and enhance the flavor and the scent of the cannabis, and their combination with the cannabinoids may alter the therapeutic impact as well.
What Are the Interactions Between Cannabinoids and Terpenes?
In terms of the entourage effect, terpenes play a significant role in the way that cannabis interacts with other cannabinoids and terpenes. It is for instance possible that some terpenes, due to their presence, could act as potentiators for the CBG activity on cannabinoid receptors 1 and 2, thereby increasing the anti-inflammatory and therapeutic effects of CBG.
It is also conceivable that by targeting the breeding for certain terpenes, cannabis products can be created, enhancing the beneficial effects of CBG and other cannabinoids.
What Are the Primary Research Directions?
We will now outline a handful of the most striking research issues.
Neuroprotective Properties
There is a lot of anticipation in CBG research for its possible neuroprotective effects. As preliminary evidence suggests, CBG may assist in neuroprotection and may also reduce neuroinflammation—hence making CBG a potential candidate for therapies aimed at diseases like Huntington’s disease, Parkinson’s, and Alzheimer’s disease. In preclinical models, CBG has demonstrated the capacity to block nerve cell death and recover from excessive protein deposition within the brain cells.
Anti-inflammatory and Antibacterial Potential
Chronic inflammation has been described as a major pathological feature responsible for systemic autoimmune diseases, cardiovascular diseases, metabolic syndrome, and other associated ailments. CBG presents a ray of hope when blended with other compounds facilitating the treatment of inflammatory bowel disease (IBD) as it is promising to contain chronic inflammation. Newer studies also highlight the distinct antimicrobial effect of CBG, particularly against drug-resistant bacteria such as MRSA. This may place CBG right into the arsenal of disease control strategies involving multi-drug resistant infections.
Glaucoma Treatment
CBG has been reported to have the ability to lower intraocular pressure which can be helpful in treating glaucoma. The working mechanism is believed to be increased blood supply with better outflow facilities therefore helping deal with the pressure that is harmful to the optic nerve. As the field is quite new, CBG perhaps can be a better option for glaucoma treatment and most importantly it eliminates side effects as well.
Appetite Stimulation and Metabolic Health
CBG has appetite-stimulating properties and could be useful for patients suffering from squamous cell carcinoma, HIV/AIDS and cachexia, where weight preservation is imperative. CBG, unlike THC, which also increases appetite but has a psychoactive component, may provide a more direct way to address appetite loss without dosage spills. Furthermore, other active research is examining CBG for its potential for improved metabolic health with implications for managing diabetes and obesity conditions.
What Are the Challenges Ahead?
In as much as the researchers are optimistic, there are serious barriers which have to be dealt with prior to acceptability of CBG as a treatment in the clinical domain.
-
Limited Clinical Trials: The research on CBG available is rather sparse; when it comes to the more developed studies, these have been conducted on animal models or in vitro. In order for CBG to be completely comprehended in terms of its therapeutic effects and side effects, more human clinical research is required. The process might be sluggish and expensive at times; however, it is necessary for the development of medicines that are CBG-based.
-
Regulatory Hurdles: Variable countries have legislation around cannabinoids that are more conservative, which really hampers research and development activities. While CBG, isolated from hemp plants, is generally distributed with lower restrictions, the approval procedures are still generally tough to go through, and they exist for the potential medical applications of the drug.
-
Production and Cost: Due to the fact that CBG is an inherent component of cannabis plants and the quantity is very little, it is not economical or easy to isolate. On the bright side, selective breeding advances, as well as lab-based synthetic methods of production, are making the substance easier to manufacture and cheaper. These developments will be particularly important for achieving the low cost of CBG-based therapies.
What is The Future Outlook?
With the evolution of cannabis research, it is evident that CBG is on course to becoming an integral component in the next generation of therapeutic approaches based on cannabinoids. Its vast potential range of uses -where the compound would assist with neuroprotection and inflammatory or antibacterial activity- makes it such a compound that it can be utilized in combating many global health challenges.
With human trials underway and cultivation methods enhancing, CBG-based full-spectrum products are expected to enter the market and possibly bring forth treatments for diseases that are currently inadequately managed.
In the future, CBG also finds application in the emerging field of personalized medicine, where cannabinoid based therapeutics are optimized according to the patient’s genetics and their disease. This would be an exciting development in the application of cannabinoids in the context of orthodox medicine.
Conclusion
CBG’s future in medical research is promising with the effectiveness of new ways to manage various health issues within reach. With time and additional studies, addressing other challenges, regulatory issues, etc. CBG may prove to be one of the non-psychotropic options available for patients who are looking for alternatives. However, there remains plenty of work to be done. The increasing volume of literature does suggest that CBG should have a therapeutic application in chronic diseases and should be widely used in the future as part of the pharmacotherapy with cannabinoids for the treatment of various pathologies.